Press release
Targeted DNA RNA Sequencing Market Set to Hit USD 70.79 Billion by 2034: A 19.4% CAGR Boost
๐๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฌ๐ข๐ณ๐ ๐จ๐ ๐ญ๐ก๐ ๐ญ๐๐ซ๐ ๐๐ญ๐๐ ๐๐๐ ๐๐๐ ๐ฌ๐๐ช๐ฎ๐๐ง๐๐ข๐ง๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฐ๐๐ฌ ๐๐ฏ๐๐ฅ๐ฎ๐๐ญ๐๐ ๐ญ๐จ ๐๐ ๐๐ญ ๐๐๐ ๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐. ๐๐ก๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ข๐ฌ ๐๐ฑ๐ฉ๐๐๐ญ๐๐ ๐ญ๐จ ๐ข๐ง๐๐ซ๐๐๐ฌ๐ ๐๐ง๐ ๐ ๐ซ๐จ๐ฐ ๐๐ซ๐จ๐ฆ ๐๐๐ ๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐ ๐ญ๐จ ๐๐๐ ๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, ๐๐ข๐ฌ๐ฉ๐ฅ๐๐ฒ๐ข๐ง๐ ๐ ๐๐๐๐ ๐จ๐ ๐๐.๐% ๐๐ซ๐จ๐ฆ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐.๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐จ๐ฉ๐:
The report mainly focuses on the growth promoters, market share, size, trends, applications in various sectors, and insight into recent advancements and difficulties in order to provide us with a thorough understanding of the targeted DNA RNA sequencing market.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐ ๐จ๐ซ ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐ฐ๐ข๐ญ๐ก ๐๐ง ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐จ๐จ๐ค ๐๐ญ ๐ญ๐ก๐ ๐๐๐ญ๐๐ฌ๐ญ ๐๐ซ๐๐ง๐๐ฌ ๐๐ง๐ ๐๐ฉ๐๐จ๐ฆ๐ข๐ง๐ ๐๐๐ฏ๐๐ง๐๐๐ฆ๐๐ง๐ญ๐ฌ: https://www.polarismarketresearch.com/industry-analysis/targeted-dna-rna-sequencing-market/request-for-sample
๐๐๐ซ๐ค๐๐ญ ๐๐๐๐ข๐ง๐ข๐ญ๐ข๐จ๐ง:
A technique for choosing and sequencing particular regions of interest in DNA or RNA molecules is called targeted DNA or RNA sequencing. Both quantitative and qualitative data regarding gene expression and genomics can be obtained using it. Targeted DNA or RNA sequencing has several uses, such as identifying gene fusion partners, RNA medication response, genetic disorders, and tumor categorization and progression. It can also be accurate and reasonably priced. Amplicon-based or enrichment-based methods can be used for targeted DNA or RNA sequencing.
๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ:
โข The speed, precision, and affordability of sequencing are improved by developments like the creation of next-generation sequencing (NGS) technologies that are driving the growth of the global targeted DNA RNA sequencing market.
โข The trend of combining targeted DNA/RNA sequencing data with other omics data, like proteomics and metabolomics, is becoming more and more prominent and are driving the global market further forward.
โข The demand for targeted sequencing is anticipated to be driven by the growing body of research in oncology.
๐๐๐๐ ๐๐จ๐ซ๐ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง? ๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐ฆ๐จ๐ซ๐ ๐๐๐จ๐ฎ๐ญ ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐๐๐จ๐ซ๐ ๐ฉ๐ฎ๐ซ๐๐ก๐๐ฌ๐: https://www.polarismarketresearch.com/industry-analysis/targeted-dna-rna-sequencing-market/inquire-before-buying
๐๐๐ฃ๐จ๐ซ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐๐ซ๐ค๐๐ญ
The market's established companies compete with one another, which propels technological developments that lead to better performance and lower sequencing service costs. Some of them are:
โข Illumina Inc.
โข Thermo Fisher Scientific
โข Agilent Technologies
โข Roche Sequencing Solutions
โข QIAGEN
โข Pacific Biosciences
โข Oxford Nanopore Technologies
โข BGI Genomics
โข Genomatix Software
โข Bio-Rad Laboratories
โข PerkinElmer
โข Hudon Alpha
โข Element Biosciences
โข Twist Bioscience
โข Nextera
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ
โข North America has the largest market share, mostly because of its sophisticated healthcare system, substantial investments in genetics and biotechnology, and high research funding. Early adoption of advanced sequencing technology and a focus on precision medicine underpin North America's dominance.
โข The market for targeted DNA/RNA sequencing is expanding steadily in Europe thanks to large R&D expenditures and a strong emphasis on precision medicine.
โข The market for targeted DNA/RNA sequencing in the Asia Pacific region is expanding rapidly due to rising investments in biotechnology and healthcare infrastructure as well as a growing focus on personalized treatment.
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/industry-analysis/targeted-dna-rna-sequencing-market
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ฅ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ
Polaris Market Research has segmented the targeted DNA RNA sequencing market report on the basis of type, method, workflow, and end user:
๐๐ฒ ๐๐ฒ๐ฉ๐ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
โข DNA-Based
โข RNA-Based
๐๐ฒ ๐๐๐ญ๐ก๐จ๐ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
โข Exome Sequencing
โข Enrichment Sequencing
โข Amplicon Sequencing
โข Others
๐๐ฒ ๐๐จ๐ซ๐ค๐๐ฅ๐จ๐ฐ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
โข Pre-sequencing
โข Sequencing
โข Data Analysis
๐๐ฒ ๐๐ง๐ ๐๐ฌ๐๐ซ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
โข Academic Research
โข Hospitals & Clinics
โข Pharma & Biotech Entities
โข Others
๐๐จ๐ฉ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐จ๐ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Ambulatory Services Market: https://www.polarismarketresearch.com/industry-analysis/ambulatory-services-market
Erectile Dysfunction Drugs Market: https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market
Durable Medical Equipment Market: https://www.polarismarketresearch.com/industry-analysis/durable-medical-equipment-market
Immuno Oncology (IO) Market: https://www.polarismarketresearch.com/industry-analysis/immuno-oncology-io-market
Gene Therapy Market: https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market
๐๐จ๐ง๐ญ๐๐๐ญ:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
๐๐๐จ๐ฎ๐ญ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก & ๐๐จ๐ง๐ฌ๐ฎ๐ฅ๐ญ๐ข๐ง๐ , ๐๐ง๐:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Targeted DNA RNA Sequencing Market Set to Hit USD 70.79 Billion by 2034: A 19.4% CAGR Boost here
News-ID: 3770954 • Views: โฆ
More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโฆ

Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected toโฆ

Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโฆ

Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโฆ
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA โฆ
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, andโฆ
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca โฆ
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,โฆ
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca โฆ
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
โข 70% efforts of Primary Research
โข 15% efforts of Secondary Research
โข 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limitedโฆ
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin โฆ
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
โข The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
โข Expected exponentialโฆ
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe โฆ
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers aโฆ
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te โฆ
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and mayโฆ